Study of Safety and Efficacy of a Basiliximab, Mycophenolate Mofetil, Cyclosporine Microemulsion and Prednisone Combination Treatment Regimen in Pediatric Renal Allograft Recipients

NCT00228020 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

212

Enrollment

INDUSTRY

Sponsor class

Conditions

Pediatric Kidney Transplantation

Interventions

DRUG: basiliximab, MMF(mycophenolate mofetil), cyclosporine, prednisone (or equivalent)
DRUG: MMF, cyclosporine, steroids

Sponsor

Novartis